Thursday, May 14, 2015

How Allergy Injection (Immunotherapy) Impact Veterans Health

Note from the Author: This information was written with inspirations taken from Allergy Clinic Veterans, Nurse Executive Director - Marilyn Crosby, Nurse Managers - Althea Phillips-Edwards, Monike Harvey, Sy Reeker, Prime Care Clinic Director - Dr. Nicholas Masozera, Allergy Clinic Doctors - Dr. Roger Rossen (initiator), Dr. Frank Orson, Dr. David Corry and Dr. Adrian Casillas, Allergy Clinic Staff Registered Nurses –Alberta E. Gudes (writer), Jodi Francis, Estelita Mansukhani, and Nathasha Mingo-Foster and all Prime Care Clinic Staff at Michael E. DeBakey Veterans Affairs Medical Center and Excerpts from  Kathryn L. McCance, Sue E. Huether, Valentina L. Brashers and Neal S. Rote.  2010. (Sixth Edition) Book:  Pathophysiology, the biologic basis for disease in adults and children. Mosby Elsevier. pp. 222, 264-269.

Allergy
   Allergy is a hypersensivity response against an environmental antigen (allergen). The most common allergies are type I hypersensitivities, although any of the other three mechanisms may cause allergic responses.  Veterans had similar experiences of the common allergens.
   Typical allergens that induce type I hypersensitivity include pollens (e.g. ragweed), molds and fungi (e.g. Penicillum notatum), foods (e.g. milk, eggs, and fish), animals (e.g. cat dander, dog dander), cigarette smoke, components of house dust (e.g. fecal pellets of house mites) and almost anything else we may encounter in our environment. Allergens that primarily elicit type IV allergic hypersensitivity include plant resins (e.g. poison ivy, poison oak), metals (e.g. nickel, chromium), acetylates and chemicals in rubber, cosmetic, detergents and topical antibiotics (e.g. neomycin). Type II and III allergic hypersensitivities are relatively rare but may include antibiotics (e.g. penicillin, sulfonamides) and soluble antigens produces by infectious agents (e.g. hepatitis B).
   Usually a sensitization process involving multiple exposures to the allergen occurs before adequate amounts of antibody or T cells are available to elicit a hypersensitivity response. In some instances, exposure to a particular allergen may not be apparent in the case of allergens that are drugs, additives, or preservatives in food. For example, milk may contain trace of amounts of penicillin used for treating cows for mastitis. Thus, the first therapeutic exposure to penicillin may cause unexpected hypersensitivity reaction. Additionally, penicillin shares a B-lactam structure with cephalosporin, so that one antibiotic may be sensitive against another.

Genetic Predisposition
   Certain individual are genetically predisposed to develop allergies, particularly type I allergies, and are called atopic. In families in which one parent has an allergy, allergies develop in about 40% of the offspring. If with both parents have allergies, the incidence in the offspring maybe as high as 80% according to Principles of Genetics.
Atopic individuals tend to produce higher quantities of IgE (immunoglobulins) and to have more Fc (crystalline fragment) receptors for IgE on their mast cells. The airways and the skin of atopic individuals are also more responsive to a wide variety of both specific and nonspecific stimuli than are the airways and individuals who are not atopic. Multiple genes have been associated with the atopic state, including polymorphism in a large variety of cytokines that regulates IgE synthesis (e.g. interleukin and cellular receptors.

Clinical Symptoms of Type I Allergies
   The clinical manifestations of type I reactions are attributable mostly to the biologic effects of histamine.  Tissues most commonly affected contain large numbers of mast cells and are sensitive to the histamine released from them. These tissues are found in the gastrointestinal tract, the skin, and the respiratory tract. The particular symptoms reflect the main portal of entry for the allergen. For instance, pollens are airborne allergens usually cause respiratory symptoms.
   Effects of allergen on the mucosa of the eyes, nose, and respiratory tract include conjunctivitis (inflammation of the membranes lining the eyelids), rhinitis (inflammation of the mucous of the membranes of the nose), and asthma (constriction of the bronchi).  Symptoms are caused by vasodilation, hypersecretion of mucus, edema, and swelling of the respiratory mucosa. Because the mucous membranes lining the respiratory tract (accessory) sinuses, nasopharynx, and upper and lower respiratory tract are continuous, they are all adversely affected. The degree to which each is affected determines the symptoms of the disease.
   Gastrointestinal allergies are caused primarily by allergens that enter through the mouth – usually foods or medicines. Symptoms include vomiting, diarrhea, or abdominal pain and may be severe enough to result in malabsorption or protein-losing enteropathy, if the reactions are prolonged or recurrent. Foods most often implicated in gastrointestinal allergies are milk, chocolate, citrus fruits, eggs, wheat, nuts, peanut butter, and fish. When food is the allergen, the active immunogen may be a product of food breakdown by digestive enzymes.
   Urticaria or hives, is a dermal (skin) manifestation of type I allergic reactions. The underlying mechanism is the localized release of histamine and increase vascular permeability, resulting in limited areas of edema. Urticaria is characterized by white fluid-filled blisters (wheals) surrounded by areas of redness (flares). The wheal and flare reaction is usually accompanied by itching. Not all urticarial symptoms are caused by allergic (immunologic) reactions. Some, termed nonimmunologic urticaria, result from exposure to cold temperatures, emotional stress, medications, systemic diseases, hyperthyroidism, or malignancies (e.g. lymphomas.)
   If possible, avoidance of the allergen is the best method to limit allergic responses. Approximately 30% of the laboratory animal handlers have allergies to animal dander and must use face masks or other devices to avoid contact.
  Although some type I allergic responses can be controlled by blocking histamine receptors with antihistamines, the primary mechanism of control is the autonomic nervous system. The autonomic nervous system includes biochemical mediators (e.g. epinephrine, acetylcholine) that, like the mediators of the inflammatory response, have profound effects on cells. These mediators bind to appropriate receptors on mast cells and target cells of the inflammation (e.g. smooth muscle) thereby controlling (1) release of inflammatory mediators from mast cells and (2) the degree of which target cells respond to inflammatory mediators.

Allergic Disease: Bee Sting Allergy
   An example of a life-threatening allergy is an anaphylactic reaction to a bee sting. Bee venom contains a mixture of enzymes and other proteins that may serve as allergens. About 1% of veterans may have anaphylactic reaction to bee venom. Within minutes they may develop excessive swelling (edema) at the bee sting site, followed by generalized hives, itching, and swelling in areas distal from sting (e.g. eyes, lips), and other systemic symptoms including flushing, sweating, dizziness, and headache. The most severe symptoms may include gastrointestinal (e.g. stomach cramps, vomiting), respiratory (e.g. tightness in the throat, wheezing, difficulties breathing), and vascular (e.g. low blood pressure, shock) reactions. Severe respiratory and vascular reactions may lead to death.
   If a veteran has had a previous anaphylactic response to bee stings, the chance of having another is about 60%.  During the reaction the administration of antihistamines has a little effect because histamines has already bound H1 receptors and initiated severe bronchial smooth muscle contraction. Most individuals carry self-injectable epinephrine. Autonomic nervous system mediators, such as epinephrine, bind to specific receptors on smooth muscle and reverse the effects of histamine and result in muscle relaxation. Similar anaphylactic reactions have been described against peanuts and other nuts, shellfish, fish, milk, eggs, and some medications.

Test of IgE-Mediated Allergy
   Allergic reaction can be life threatening; therefore, it is essential that severely allergic individuals be made aware of the specific allergen against which they are sensitized and instructed to avoid contact with that material. Several tests are available, including food challenges, skin tests with allergens, and laboratory tests for total IgE and allergen-specific IgE in the blood.
   Reactivity to a particular food allergen may be tested by controlled administration of small doses of the suspected allergen in order to evoke a mild allergic response. This approach can be dangerous if the individual has history of anaphylactic responses. A safer approach is injection of an allergen into (intradermal) or onto (epicutaneous or prick test) the skin. The individual is allergic to a particular allergen, a local wheal and flare reaction within a few minutes at the site of injection. The diameter of the flare reaction is usually indicative of the individual’s degree of sensitivity to that allergen. In the most severely allergic individuals even the extremely small amounts of allergen used for the skin tests may evoke a systemic anaphylaxis. Skin test is also contraindicated if the patient is using medications that may affect the test or has diffuse dermatitis, which would make the reaction difficult to interpret.

Desensitization (Immunotherapy)
   Clinical desensitization to allergens can be achieved in some individuals.  Minute quantities of the allergen are injected in increasing doses over a prolonged period. The procedure may reduce the severity of the allergic reaction in the treated individual. However, this form of therapy is associated with a risk of systemic anaphylaxis, which can be severe and life threatening. This approach works best for allergies against some food allergens and with biting insect allergies (80% to 90% rate of desensitization over 5 years of treatment.
   The mechanism by which desensitization occurs maybe several, one of which is the production of large amounts of so-called blocking antibody, usually circulating IgG. A blocking antibody presumably competes in the tissues or in the circulation for binding with antigenic determinants on the allergen so that the allergen is “neutralized” and is unable to bind with IgE on mast cells. Desensitization injections also may stimulate the generation of clones of regulatory T lymphocytes, which inhibit hypersensitivity by suppressing the production of IgE or modifying the Th1/Th2 interactions in favor of production of anti-inflammatory cytokines.

Benefits for Staff
   The established knowledge above, benefits the Allergy Clinic change from one day “Friday” 09:00-11:00 AM to three days “Monday, Wednesday, and Thursdays from 08:00 to 10:00 AM:
(1)  Allergy staff nurses can attend the Prime Care Staff meeting from 08:00 to 09:00 AM on Fridays which appropriately can include a robust sense of communication and collegiality of the Prime Care Clinic and updates nursing management challenges and changes from the Nursing Management view.
(2)  Allergy clinic veterans expected and provided with exclusive allergy nursing skills that another may not possess e.g. veterans has other day’s options to take allergy injections.
(3)  Allergy team members feel that very high quality patient care is delivered with safe and supportive environment.
(4)  It is very rewarding to see challenging high-risk allergy clinic patients become better self-managers, teachers and motivators for other patients, and have improved health outcome.

 Benefits for Veterans
(1)  Veterans may benefit from the one-on-one visit access to multiple disciplines or areas of expertise (allergy disease medication management, nutrition, and behavioral/motivation experts e.g. smoking cessation counseling) while taking allergy injections or immunotherapy.
(2)  Patients also benefit from the experience of other patients participating in the group allergy clinic (peer support) with allergy staff guidance, patients learn from each other about solutions to tackle the day-to-day challenges in a way that is impossible to achieve in traditional clinic visits.

(3)  Finally, the patients gain commitment, a sense of control; usually voiced experience improved health, and need to come to allergy clinic weekly even the every other weekly maintenance dosing was reached.

Houston Chronicle Salute to Nurses 2015 Entree Awarded

My Nominee, Estellita Mansukhani, was awarded as one of the Top 150 Nurses at Houston Chronicle Salute To Nurses 2015. So proud of Estee, in red, one of my best friend and partner in Allergy Clinic, we work very hard in keeping up patient's health safety at Allergy/Immunotherapy. Go to link below:
http://www.chron.com/jobs/salute-to-nurses/

Tuesday, May 12, 2015

Nurse Blogger First Participant: Call for Nurse Authors

"Congratulations!! First Submission by a Nurse Blogger Ms. Alberta Gudes, MSN, ED, RN Prime Care Clinic Read all about it! [Honoring all Nurse Authors! MEDVAMC Nurses Week Celebration May 7, 2015/AUD) Sponsors: MCL & NRC‏" 

~ B. Cozart, PhD, RN


***
Do you know what a “blog” is?
What is a "blog"?
"Blog" is an abbreviated version of "weblog," which is a term used to describe websites that maintain an ongoing chronicle of information. A blog features diary-type commentary and links to articles on other websites, usually presented as a list of entries in reverse chronological order. Blogs range from the personal to the political, and can focus on one narrow subject or a whole range of subjects.
***
Alberta’s Perspective on:
Predicting The Career Potential For Nurse Educators In Online Education
 Application of Technology in Nursing and Patient Education

Nursing In My Perspective

Thursday, July 19, 2012
Huberta "Bette" T. Cozart, PhD, RN
Interim Chair, Nursing Research Council
Member-Institutional Review Board (IRB) Panel#4, Baylor College of Medicine
Instructor, Baylor College of Medicine Department of Physical Medicine & Rehabilitation
Spinal Cord Injury Care Line, Clinical Nurse Educator
Michael E. DeBakey VA Medical Center
2002 Holcombe, Office 1B-168
Houston, Texas 77030
tel #: (713) 791-1414 X 27994
'I've learned that people will forget what you said, people will forget what you did, but people will never forget how you made them feel.'  [Maya Angelou]
I’ve learned that being part of the solution forges a new path for personal growth. [Dr. Bette]
“Knowing is not enough; we must apply. Willing is not enough; we must do.” Goethe
From doubting what if – to acting what can be. [Dr Bette]

A Report On Colorectal Cancer Screening Perceptions of Hispanic/Latino